Health Condition 1: H578- Other specified disorders of eye and adnexa
Conditions
Interventions
Intervention1: To compare the predicted vault and rotational stability between the EVO TICL versus the Eyecryl phakic toric IOL in correcting myopic astigmatism: To compare the predicted vault and rot
Sponsors
Nethradhama Super Speciality Eye Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Patients with myopic astigmatism motivated to undergo correction who are less than 40 years of age Best corrected Visual acuityof 20/40 or better. Healthy tear film and ocular surface Anterior chamber depth more than or equal to 2.8mm. Endothelial cell count more than 2000 cells/mm2. Absence of corneal ectatic diseases, corneal scars, absence of retinal pathologies
Exclusion criteria
Exclusion criteria: Corneal ectatic diseases, corneal scars, retinal pathologies Active ocular disease in the operating eye such as uveitis, glaucoma, diabetic retinopathy and corneal disorders including scars, opacities, and degenerations Progressive or unstable myopia and/or astigmatism. Previous ocular surgery. Dysfunctional lens syndrome, any evidence of cataract. Anterior chamber depth less than 2.8mm. Endothelial cell counts less than 2000 cells/mm2.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the predicted vault and rotational stability between the EVO TICL versus the Eyecryl phakic toric IOL in correcting myopic astigmatismTimepoint: day 1, 2 weeks, 3 months and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the Visual and refractive outcomes between the EVO TICL and the Eyecryl phakic toric IOLTimepoint: day 1, 2 weeks, 3 months and 6 months | — |
Countries
India
Contacts
Public ContactDr Varshitha C
Nethradhama Super Speciality Eye Hospital
Outcome results
None listed